The Long Run with Luke Timmerman cover image

Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery

The Long Run with Luke Timmerman

00:00

How Big of a Life Anger Was This for You as a Co-Founder?

A company a was acquired saljean now part of beamess for i mean, multiple billions. Ithink animod is the a, a generic, generic name, but it's a small molecule that binds with a g pc r a target. A has that agonised effect, as you mention, treatment for multipl sclerosis and now ulcerative colidus. We we went public, i think, in 20 13. And then we wan a guinea, acquired by saljean for  a little over seven billion us. Well, one or two billion. You know, what's the differenceh ha ho.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app